Phase 1 study of the PI3Kdelta inhibitor INCB040093 {+/-} JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma - Phillips, T. J., Forero-Torres, A., Sher, T., Diefenbach, C. S., Johnston, P., Talpaz, M., Pulini, J., Zhou, L., Scherle, P., Chen, X., Barr, P. M. (American Society of Hematology (ASH), 2018)
6306584
Keywords: W; WW-YZ